TG Therapeutics, Inc. (TGTX)
NCM – Real Time Price. Currency in USD
50.23
+0.33 (0.66%)
Market open: Aug 12, 2026, 10:08 AM EDT
49.90
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
50.23
+0.33 (0.66%)
Market open: Aug 12, 2026, 10:08 AM EDT
49.90
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Total debt $754.4M significantly exceeds cash reserves ($482.6M), raising financial stability concerns
Total current assets $1.1B exceed Total current liabilities $268.5M, highlighting excellent liquidity
Debt-to-equity ratio (1.2) is near the industry average, reflecting balanced leverage
Interest coverage ratio (1.3x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $39.0M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.27 | 6.05 | 10 | |
| Quick ratio | 3.72 | 5.63 | 10 | |
| Debt to Equity | 1.25 | 0.30 | 6.0 | |
| Debt to Assets | 0.46 | 1.04 | 5.0 | |
| Interest coverage | 1.31 | -16.91 | 4.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 234M | 329M | 616M | 800M |
| Gross Profit | 2M | 219M | 290M | 516M | 659M |
| Operating Income | -193M | 21M | 42M | 123M | 136M |
| Net Income | -198M | 13M | 23M | 447M | 441M |
| EBITDA | -192M | 21M | 42M | 125M | 137M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 52.78 | -85.48 | 5.5 |
| Next quarter | 39.13 | 203.78 | 10 |
| Current year | 55.43 | -63.78 | 5.5 |
| Next year | 37.6 | 185.24 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 17.28 | -60.65 | -58.32 | 317.16 | 5.3 |
| Y/Y | 70.27 | -72.39 | -70.58 | 427.05 | 5.5 |
| 3y average | 2806.05 | 667.77 | 639.83 | 30.49 | 10 |
| 5y average | 2532.09 | 404.35 | 391.06 | 18.84 | 9.8 |
| Weighted average score | 7.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |